The tyrosine phosphatase SHP2 regulates Sertoli cell junction complexes.

The blood-testis barrier (BTB) is a complex junctional structure that separates developing germ cells from the bloodstream. This barrier is crucial for maintaining the unique microenvironment needed for spermatogenesis. While the role of tyrosine phosphorylation in BTB regulation is known, the specific enzymes and signaling pathways involved remain unclear. Prior research has shown that tight junctions and adherens junctions are regulated by phosphorylation events, but the role of phosphatases like SHP2 has not been fully explored. This gap motivated the investigation into SHP2's potential role in BTB regulation. No prior work had resolved how SHP2 might influence junctional integrity in Sertoli cells. Understanding this could provide new insights into male fertility and spermatogenesis. The study aims to clarify SHP2's function in BTB dynamics. This research is distinct from general studies on testicular function by focusing on a specific phosphatase. The findings may contribute to broader understanding of testicular physiology.

This study aims to determine whether SHP2, a nonreceptor tyrosine phosphatase, regulates the integrity of the blood-testis barrier (BTB) in Sertoli cells. The BTB is essential for spermatogenesis and male fertility. The researchers propose that SHP2 may influence BTB dynamics through its effects on tyrosine phosphorylation of junctional proteins. The motivation for this work stems from the known role of tyrosine phosphorylation in junctional regulation and the lack of understanding about phosphatases like SHP2 in this context. The study focuses on SHP2's localization and activity in Sertoli-Sertoli junctions. The goal is to assess how SHP2 affects junctional proteins and signaling pathways. The research is driven by the need to understand how phosphatases regulate BTB function. This could lead to new insights into the molecular mechanisms underlying male infertility.

The researchers used primary rat Sertoli cells in culture to investigate SHP2's role in BTB regulation. They localized SHP2 in Sertoli-Sertoli junctions using immunofluorescence techniques. To assess SHP2 activity, they overexpressed a constitutively active mutant, SHP2 Q79R, in cultured cells. The effects of SHP2 activation on junctional integrity were evaluated by measuring the localization of tight junction and adherens junction proteins. They also examined the impact of SHP2 on Src kinase and ERK1/2 signaling pathways. Focal adhesion kinase (FAK) interactions with SHP2 were analyzed using co-immunoprecipitation. Changes in tyrosine phosphorylation of FAK were monitored to determine SHP2's regulatory role. The actin cytoskeleton and junctional protein localization were visualized using fluorescence microscopy.

Overexpression of SHP2 Q79R in Sertoli cells increased ERK1/2 activity via Src kinase. SHP2 was found to interact with FAK, and its activation reduced FAK tyrosine phosphorylation. Expression of SHP2 Q79R led to the mislocalization of N-cadherin, β-catenin, and ZO-1 away from the plasma membrane. Tight junction and adherens junction integrity was compromised in cells expressing the active SHP2 mutant. The actin cytoskeleton was disrupted in these cells, indicating structural instability. SHP2 localization at Sertoli-Sertoli junctions suggests a direct role in BTB regulation. The loss of junctional proteins from the membrane correlated with SHP2 activity. These findings suggest SHP2 may regulate BTB integrity through tyrosine phosphatase activity.

SHP2 is localized to Sertoli-Sertoli junctions and appears to regulate BTB integrity. The study suggests that SHP2 may influence junctional proteins through tyrosine phosphatase activity. SHP2 activation leads to increased ERK1/2 activity via Src kinase, which may affect junctional stability. FAK tyrosine phosphorylation is reduced in the presence of active SHP2. The mislocalization of junctional proteins correlates with SHP2 activity. These findings indicate SHP2 may be a key regulator of BTB function. The disruption of the actin cytoskeleton suggests structural consequences of SHP2 activity. The results support the hypothesis that SHP2 plays a role in Sertoli cell support of spermatogenesis.